Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 18,026 |
|
|||||
| News | - | ||||||
| Day High | 2.76 | Low High |
|||||
| Day Low | 2.60 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| TherapeuticsMD Inc | TXMD | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.16 | 6.2% | 2.74 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.60 | 2.60 | 2.76 | 2.74 | 2.58 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 318 | 18,026 | $ 2.65 | $ 47,849 | - | 1.95 - 7.18 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:34:39 | 5 | $ 2.61 | USD |
TherapeuticsMD Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 28.98M | 10.58M | - | 69.96M | 112M | 10.59 | 0.26 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
TherapeuticsMD News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TXMD Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.72 | 2.99 | 2.58 | 2.78 | 16,407 | 0.02 | 0.74% |
| 1 Month | 2.20 | 3.07 | 2.00 | 2.49 | 23,045 | 0.54 | 24.55% |
| 3 Months | 3.64 | 3.7272 | 1.95 | 2.69 | 20,375 | -0.90 | -24.73% |
| 6 Months | 4.19 | 4.50 | 1.95 | 3.42 | 22,125 | -1.45 | -34.61% |
| 1 Year | 4.56 | 7.18 | 1.95 | 4.80 | 53,751 | -1.82 | -39.91% |
| 3 Years | 1.34 | 11.69 | 0.1503 | 1.26 | 3,917,358 | 1.40 | 104.48% |
| 5 Years | 5.07 | 11.69 | 0.1503 | 1.74 | 3,832,135 | -2.33 | -45.96% |
TherapeuticsMD Description
| TherapeuticsMD Inc is a major drug manufacturing with a focus on creating and commercializing products targeted exclusively for women. The company intends to commercialize advanced hormone therapy pharmaceutical products. TherapeuticsMD's drug candidates that have completed clinical trials are designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies, including hot flashes, osteoporosis, and discomfort. The company relies on third parties for the production of clinical and commercial quantities of its drug candidates. |
